Fate Therapeutics
FATE
FATE
78 hedge funds and large institutions have $216M invested in Fate Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
7.39% more ownership
Funds ownership: 61.35% → 68.75% (+7.4%)
5% more funds holding
Funds holding: 74 → 78 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
78
Holding in Top 10
1
Calls
$46K
Puts
$8K
Top Buyers
| 1 | +$24.7M | |
| 2 | +$23.8M | |
| 3 | +$12.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.21M |
| 5 |
Millennium Management
New York
|
+$1.86M |
Top Sellers
| 1 | -$8.96M | |
| 2 | -$1.53M | |
| 3 | -$459K | |
| 4 |
Renaissance Technologies
New York
|
-$456K |
| 5 |
TI
Telemetry Investments
New York
|
-$421K |